Despite the need for advanced hemodynamic monitoring, the role of the pulmonary artery catheter (PAC) in cardiogenic shock (CS) remains controversial due to conflicting evidence from previous studies.
Material and Methods
This single-center retrospective study utilized the MIMIC-IV database to assess the impact of PAC use on 30-day in-hospital mortality and clinical outcomes in CS patients admitted between 2008 and 2019. Propensity score matching (PS) and inverse propensity treatment weighting (IPTW) were employed to adjust for baseline differences. The primary outcome was 30-day in-hospital mortality; secondary outcomes included hospital and ICU length of stay and complications. Cox proportional hazard ratio analyses were performed to evaluate the association between PAC use and mortality outcomes.
Results
The final cohort consisted of 1940 adult CS patients, with 134 receiving PAC and 1806 not. PAC use significantly reduced 30-day in-hospital mortality (PS-matched HR 0.57, 95% CI: 0.39-0.83; IPTW HR 0.58, 95% CI: 0.35-0.96) but was associated with longer hospital stays (16.47 vs 12.37 days) and ICU stays (9.26 vs 7.52 days).
Conclusion
PAC use in CS patients was associated with improved short-term survival but also with longer hospitalization and potential complications, underscoring the need for careful patient selection and further research.
VahdatpourCCollinsDGoldbergS. Cardiogenic shock. J Am Heart Assoc. 2019;8(8):e011991. doi:10.1161/JAHA.119.011991
2.
ReynoldsHRHochmanJS. Cardiogenic shock: Current concepts and improving outcomes. Circulation. 2008;117(5):686–697. doi:10.1161/CIRCULATIONAHA.106.613596
3.
Writing Committee Members, ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Card Fail. 2022;28(5):e1–e167. doi:10.1016/j.cardfail.2022.02.010
4.
LaghlamDBenghanemSOrtunoS, et al.Management of cardiogenic shock: A narrative review. Ann Intensive Care. 2024;14(1):45. doi:10.1186/s13613-024-01260-y
5.
HarveySHarrisonDASingerM, et al.Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): A randomised controlled trial. Lancet Lond Engl. 2005;366(9484):472–477. doi:10.1016/S0140-6736(05)67061-4
6.
BaranDAGrinesCLBaileyS, et al.SCAI Clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019;94(1):29–37. doi:10.1002/ccd.28329
7.
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: The ESCAPE trial. JAMA. 2005;294(13):1625. doi:10.1001/jama.294.13.1625
8.
RéaABBACMihajlovicVVishram-NielsenJKK, et al.Pulmonary artery catheter usage and impact on mortality in patients with cardiogenic shock: Results from a Canadian single-centre registry. Can J Cardiol. 2024;40(4):664–673. doi:10.1016/j.cjca.2023.12.005
YancyCWJessupMBozkurtB, et al.2013 ACCF/AHA guideline for the management of heart failure: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810–1852. doi:10.1161/CIR.0b013e31829e8807
11.
KadoshBSBergDDBohulaEA, et al.Pulmonary artery catheter use and mortality in the cardiac intensive care unit. JACC Heart Fail. 2023;11(8 Pt 1):903–914. doi:10.1016/j.jchf.2023.04.007
JohnsonAEWBulgarelliLShenL, et al.MIMIC-IV, a freely accessible electronic health record dataset. Sci Data. 2023;10(1):1. doi:10.1038/s41597-022-01899-x
14.
HoDEImaiKKingGStuartEA. MatchIt: Nonparametric preprocessing for parametric causal inference. J Stat Softw. 2011;42(8):1–28. doi:10.18637/jss.v042.i08
15.
SeppalaLJVan De LooBSchutM, et al.A propensity score matched approach to assess the associations of commonly prescribed medications with fall risk in a large harmonized cohort of older ambulatory persons. Drugs Aging. 2021;38(9):797–805. doi:10.1007/s40266-021-00876-0
16.
GaranARKanwarMThayerKL, et al.Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality. JACC Heart Fail. 2020;8(11):903–913. doi:10.1016/j.jchf.2020.08.012
17.
SotomiYSatoNKajimotoK, et al.Impact of pulmonary artery catheter on outcome in patients with acute heart failure syndromes with hypotension or receiving inotropes: From the ATTEND Registry. Int J Cardiol. 2014;172(1):165–172. doi:10.1016/j.ijcard.2013.12.174
18.
DoshiRPatelKPatelPMerajPM. Trends in the utilization and in-hospital mortality associated with pulmonary artery catheter use for cardiogenic shock hospitalizations. Indian Heart J. 2018;70(Suppl 3):S496–S498. doi:10.1016/j.ihj.2018.08.021
19.
National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, WheelerAPBernardGR, et al.Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006;354(21):2213–2224. doi:10.1056/NEJMoa061895
20.
SandhamJDHullRDBrantRF, et al.A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348(1):5–14. doi:10.1056/NEJMoa021108
21.
ChowJYVadakkenMEWhitlockRP, et al.Pulmonary artery catheterization in patients with cardiogenic shock: A systematic review and meta-analysis. Can J Anaesth J Can Anesth. 2021;68(11):1611–1629. doi:10.1007/s12630-021-02083-2
22.
BertainaMGalluzzoARosselloX, et al.Prognostic implications of pulmonary artery catheter monitoring in patients with cardiogenic shock: A systematic review and meta-analysis of observational studies. J Crit Care. 2022;69:154024. doi:10.1016/j.jcrc.2022.154024
23.
LeeJLeeJBKimARHyunJLeeSEKimMS. Effectiveness of pulmonary artery catheter monitoring for patients with cardiogenic shock of various causes: A systematic review and meta-analysis. J Thorac Dis. 2023;15(3):1115–1123. doi:10.21037/jtd-22-1139
24.
BasirMBKapurNKPatelK, et al.Improved outcomes associated with the use of shock protocols: Updates from the national cardiogenic shock initiative. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2019;93(7):1173–1183. doi:10.1002/ccd.28307
25.
ThayerKLZweckEAyoutyM, et al.Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock. Circ Heart Fail. 2020;13(9):e007099. doi:10.1161/CIRCHEARTFAILURE.120.007099
26.
RosselloXVilaMRivas-LasarteM, et al.Impact of pulmonary artery catheter use on short- and long-term mortality in patients with cardiogenic shock. Cardiology. 2017;136(1):61–69. doi:10.1159/000448110
27.
SionisARivas-LasarteMMebazaaA, et al.Current use and impact on 30-day mortality of pulmonary artery catheter in cardiogenic shock patients: Results from the CardShock study. J Intensive Care Med. 2020;35(12):1426–1433. doi:10.1177/0885066619828959
28.
SidhuGPancholySBajajA, et al.TCT-511 Does Pulmonary Artery Catheterization improve in-hospital outcomes in patients with cardiogenic shock: ANALYSIS FROM NATIONAL INPATIENT SAMPLE (NIS). J Am Coll Cardiol. 2017;70(18):B211. doi:10.1016/j.jacc.2017.09.627
29.
WienerRSWelchHG. Trends in the use of the pulmonary artery catheter in the United States, 1993–2004. JAMA. 2007;298(4):423–429. doi:10.1001/jama.298.4.423
30.
HarveySYoungDBramptonW, et al.Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev. 2006;3:CD003408. doi:10.1002/14651858.CD003408.pub2
31.
IkutaKWangYRobinsonAAhmadTKrumholzHMDesaiNR. National trends in use and outcomes of pulmonary artery catheters among medicare beneficiaries, 1999–2013. JAMA Cardiol. 2017;2(8):908–913. doi:10.1001/jamacardio.2017.1670
32.
HernandezGALemorABlumerV, et al.Trends in utilization and outcomes of pulmonary artery catheterization in heart failure with and without cardiogenic shock. J Card Fail. 2019;25(5):364–371. doi:10.1016/j.cardfail.2019.03.004
